×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [2]
昆明医科大学 [2]
西安交通大学 [1]
南京地理与湖泊研究所 [1]
山东大学 [1]
吉林大学白求恩第一医... [1]
更多...
内容类型
期刊论文 [12]
发表日期
2019 [12]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
发表日期:2019
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/04
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
A worldwide perspective of sepsis epidemiology and survival according to age: Observational data from the ICON audit
期刊论文
JOURNAL OF CRITICAL CARE, 2019, 卷号: 51
作者:
Kotfis, Katarzyna
;
Wittebole, Xavier
;
Jaschinski, Ulrich
;
Sole-Violan, Jordi
;
Kashyap, Rahul
收藏
  |  
浏览/下载:60/0
  |  
提交时间:2019/12/04
Mortality
Outcome
ICU
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Li, X.
;
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
A worldwide perspective of sepsis epidemiology and survival according to age: Observational data from the ICON audit
期刊论文
JOURNAL OF CRITICAL CARE, 2019, 卷号: 51
作者:
Dadak, L.
;
Lahkar, B.
;
Mandal, A.
;
Sircar, M.
;
Ghosh, S.
收藏
  |  
浏览/下载:86/0
  |  
提交时间:2019/12/05
Mortality
Outcome
ICU
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/11/19
rheumatoid arthritis
certolizumab pegol
tumour necrosis factor-alpha
DMARD
Chinese
An air-stable and waterproof lithium metal anode enabled by wax composite packaging
期刊论文
Science Bulletin, 2019, 卷号: Vol.64 No.13, 页码: 910-917
作者:
Zhang, Y.
;
Lv, W.
;
Huang, Z.
;
Zhou, G.
;
Deng, Y.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/11/21
Air-stable
Dendrite
Lithium metal anode
Lithium sulfur battery
Waterproof
Impact of Graphene Exposure on Microbial Activity and Community Ecosystem in Saliva
期刊论文
2019, 卷号: 2, 期号: 1, 页码: 226-235
作者:
Shi Y.[1,2,3]
;
Xia W.[1,2,3]
;
Liu S.[4,5]
;
Guo J.[4,5]
;
Qi Z.[1,2,3]
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/16
Evaluation of lncrna anril potential in hepatic cancer progression
期刊论文
Journal of Environmental Pathology, Toxicology and Oncology, 2019, 卷号: 38, 期号: 2, 页码: 119-131
作者:
Ji Y.
;
Sun H.
;
Liang H.
;
Wang Y.
;
Lu M.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/11
ANRIL
Hepatocellular carcinoma
MiR-384
STAT3
©版权所有 ©2017 CSpace - Powered by
CSpace